Effectiveness and Safety of Filgrastim (Neupogen™) versus Filgrastim-aafi (Nivestim™) in Primary Prophylaxis of Chemotherapy-Induced Febrile Neutropenia: An Observational Cohort Study
Article in Drugs - Real World Outcomes (September 2022)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Article in Drugs - Real World Outcomes (September 2022)
Article in Journal of the National Comprehensive Cancer Network (August 2021)
Article in Supportive Care in Cancer (November 2018)